Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | BioSig Technologies, Inc.: BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected | 61 | GlobeNewswire (Europe) | LOS ANGELES and VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ("BioSig" or the "Company"), which recently merged with Streamex Exchange Corporation ("Streamex")... ► Artikel lesen | |
BIOSIG TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
15.08. | BioSig Technologies raises $15 million in public offering | 1 | Investing.com | ||
15.08. | BioSig completes $15 million public offering to fund gold bullion purchases | 6 | Investing.com | ||
15.08. | BioSig schließt Kapitalerhöhung über 15 Millionen US-Dollar für Goldkäufe ab | 3 | Investing.com Deutsch | ||
15.08. | BioSig Technologies schließt Kapitalerhöhung über 15 Millionen US-Dollar ab | 2 | Investing.com Deutsch | ||
15.08. | BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering | 1 | GlobeNewswire (USA) | ||
15.08. | BioSig Technologies, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
14.08. | BioSig to raise $15M in offering, plans to invest in bullion and support corporate needs | 1 | Seeking Alpha | ||
14.08. | BioSig prices $15 million public offering of common stock | 1 | Investing.com | ||
14.08. | BioSig Technologies, Inc.: BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering | 2 | GlobeNewswire (USA) | ||
13.08. | BioSig kündigt öffentliche Emission von Stammaktien zur Finanzierung von Goldkäufen an | 4 | Investing.com Deutsch | ||
13.08. | BioSig announces public offering of common stock to fund gold purchases | 1 | Investing.com | ||
13.08. | BioSig Technologies, Inc.: BioSig Technologies Inc. Announces Proposed Public Offering | 2 | GlobeNewswire (USA) | ||
13.08. | BioSig Technologies ändert Wandelanleihen-Vereinbarung mit Yorkville über bis zu 100 Mio. US-Dollar | 8 | Investing.com Deutsch | ||
13.08. | BioSig Technologies, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
25.07. | BioSig Technologies and Streamex: pioneering real-world asset tokenization in the US | 11 | iNVEZZ.com | ||
17.07. | Streamex (BSGM) CEO Henry McPhie highlights BSGM merger, RWA tokenization strategy in Live TV interview | 3 | iNVEZZ.com | ||
14.07. | BSGM engages CXG to acquire FINRA/SEC-registered broker-dealer to expand publicly traded RWA tokenization operations | 3 | iNVEZZ.com | ||
14.07. | BioSig Technologies partners with Compliance Exchange to acquire FINRA/SEC broker-dealer to boost RWA tokenization | 3 | Seeking Alpha | ||
14.07. | BioSig engages broker-dealer acquisition for gold token launch | 2 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,106 | -4,50 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,665 | +0,45 % | RedChip Companies, Inc.: NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 29, 2025 / RedChip Companies will air interviews with NioCorp Developments Ltd. (Nasdaq:NB) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip Small Stocks... ► Artikel lesen | |
PING AN HEALTHCARE | 2,402 | -5,13 % | HSI Closes at 25,343, Down 153 pts; HSTI Closes at 5,683, Down 44 pts; BYD ELECTRONIC Down over 4%; CSPC PHARMA, CHOW TAI FOOK, MEDBOT-B, PA GOODDOCTOR, WUXI XDC Hit New Highs; Market Turnover Rises | ||
MOUNTAIN VALLEY MD | 0,004 | +200,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,260 | -6,47 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
CYTOSORBENTS | 0,820 | -2,26 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
VERU | 3,280 | -0,91 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
VOLITIONRX | 0,644 | -2,91 % | VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, August 15 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., Aug. 14, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
EKSO BIONICS | 4,040 | -4,49 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 5,040 | +2,34 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
BEYOND AIR | 2,170 | -5,65 % | Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Japan | GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 41,710 | -0,45 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
FRESENIUS | 47,180 | +1,42 % | Fresenius: Analysten heben Kursziel kräftig an und schüren neue Fantasie für Gesundheitsaktie | Fresenius erhält von der UBS ein deutlich höheres Kursziel, da Analysten dem Gesundheitskonzern neue Wachstumschancen zutrauen. Die Empfehlung zum Kauf bleibt bestehen, während Experten weiteres Aufwärtspotenzial... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,140 | +1,03 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |